Literature DB >> 7723963

Physiology of fatigue in amyotrophic lateral sclerosis.

K R Sharma1, J A Kent-Braun, S Majumdar, Y Huang, M Mynhier, M W Weiner, R G Miller.   

Abstract

We investigated the mechanisms of muscle fatigue in ALS. In the muscles of ALS patients and healthy control subjects, we examined (1) fatigue using measurements of muscle force, (2) energy metabolism using phosphorus-31 magnetic resonance spectroscopy, and (3) activation using neurophysiologic measures and MRI. During 25 minutes of intermittent isometric exercise of the tibialis anterior muscle, both maximum voluntary and tetanic force declined more in patients than in controls, indicating greater fatigability in ALS. There was a similar decline of voluntary and tetanic force, suggesting that much of the fatigue was not central. Evoked compound muscle action potential amplitudes were preserved during exercise in both groups, indicating no failure of neuromuscular transmission; this result suggests that the source of fatigue was not at the neuromuscular junction or within the muscle membrane. In spite of greater fatigability, changes during exercise in energy metabolites and proton signal intensity tended to be less in ALS patients compared with controls, suggesting impaired muscular activation. We conclude that the greater muscle fatigue in ALS patients results from activation impairment, due in part to alterations distal to the muscle membrane.

Entities:  

Mesh:

Year:  1995        PMID: 7723963     DOI: 10.1212/wnl.45.4.733

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

1.  Advances in the application of MRI to amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Michel Modo
Journal:  Expert Opin Med Diagn       Date:  2010-11

2.  Speech-related fatigue and fatigability in Parkinson's disease.

Authors:  Matthew J Makashay; Kevin R Cannard; Nancy Pearl Solomon
Journal:  Clin Linguist Phon       Date:  2014-08-25       Impact factor: 1.346

3.  Decreased muscle endurance associated with diabetic neuropathy may be attributed partially to neuromuscular transmission failure.

Authors:  Matti D Allen; Kurt Kimpinski; Timothy J Doherty; Charles L Rice
Journal:  J Appl Physiol (1985)       Date:  2015-02-05

4.  A comparative analysis of spectral exponent estimation techniques for 1/f(β) processes with applications to the analysis of stride interval time series.

Authors:  Alexander Schaefer; Jennifer S Brach; Subashan Perera; Ervin Sejdić
Journal:  J Neurosci Methods       Date:  2013-11-04       Impact factor: 2.390

Review 5.  The muscular dystrophies: from genes to therapies.

Authors:  Richard M Lovering; Neil C Porter; Robert J Bloch
Journal:  Phys Ther       Date:  2005-12

6.  A Human-Based Functional NMJ System for Personalized ALS Modeling and Drug Testing.

Authors:  Xiufang Guo; Virginia Smith; Max Jackson; My Tran; Michael Thomas; Aakash Patel; Eric Lorusso; Siddharth Nimbalkar; Yunqing Cai; Christopher W McAleer; Ying Wang; Christopher J Long; James J Hickman
Journal:  Adv Ther (Weinh)       Date:  2020-08-11

7.  Fatigue and activity dependent changes in axonal excitability in amyotrophic lateral sclerosis.

Authors:  Steve Vucic; Arun V Krishnan; Matthew C Kiernan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-19       Impact factor: 10.154

8.  Selective Motor Neuron Resistance and Recovery in a New Inducible Mouse Model of TDP-43 Proteinopathy.

Authors:  Krista J Spiller; Claudia J Cheung; Clark R Restrepo; Linda K Kwong; Anna M Stieber; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2016-07-20       Impact factor: 6.167

9.  Computer-aided analysis of gait rhythm fluctuations in amyotrophic lateral sclerosis.

Authors:  Yunfeng Wu; Sridhar Krishnan
Journal:  Med Biol Eng Comput       Date:  2009-08-26       Impact factor: 2.602

Review 10.  Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis.

Authors:  Colin J Mahoney; Rebekah M Ahmed; William Huynh; Sicong Tu; Jonathan D Rohrer; Richard S Bedlack; Orla Hardiman; Matthew C Kiernan
Journal:  CNS Drugs       Date:  2021-05-15       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.